Timetable

Immediate -- 4th quarter 2008

Demonstrate prototype mechanized handpiece

Secure funding for short and medium-term phase

Short-term -- 3rd quarter 2009

Produce and test prototype bioprobes

Complete Quality Control Systems for FDA requirements

Obtain Institutional Review Board approval for subject testing

Begin testing of prototypes on subjects

Medium-term -- early 2010

Obtain FDA approval for marketing cervical mapping device

Market cervical mapping device

Complete preclinical testing of bioprobe

Begin full clinical trials for bioprobe

Long-term -- midyear 2011

Complete clinical trials of bioprobe

Long term -- 2012

Obtain FDA approval for bioprobe

Market bioprobe for Pap test replacement